Herpes Simplex Virus Type 1 Preferentially Targets Human Colon Carcinoma: Role of Extracellular Matrix
- 15 January 2008
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 82 (2), 999-1010
- https://doi.org/10.1128/jvi.01769-07
Abstract
Viral therapy of cancer (viral oncolysis) is dependent on selective destruction of the tumor tissue compared with healthy tissues. Several factors, including receptor expression, extracellular components, and intracellular mechanisms, may influence viral oncolysis. In the present work, we studied the potential oncolytic activity of herpes simplex virus type 1 (HSV-1), using an organ culture system derived from colon carcinoma and healthy colon tissues of mouse and human origin. HSV-1 infected normal colons ex vivo at a very low efficiency, in contrast to high-efficiency infection of colon carcinoma tissue. In contrast, adenoviral and lentiviral vectors infected both tissues equally well. To investigate the mechanisms underlying the preferential affinity of HSV-1 for the carcinoma tissue, intracellular and extracellular factors were investigated. Two extracellular components, collagen and mucin molecules, were found to restrict HSV-1 infectivity in the healthy colon. The mucin layer of the healthy colon binds to HSV-1 and thereby blocks viral interaction with the epithelial cells of the tissue. In contrast, colon carcinomas express small amounts of collagen and mucin molecules and are thus permissive to HSV-1 infection. In agreement with the ex vivo system, HSV-1 injected into a mouse colon carcinoma in vivo significantly reduced the volume of the tumor. In conclusion, we describe a novel mechanism of viral selectivity for malignant tissues that is based on variance of the extracellular matrix between tumor and healthy tissues. These insights may facilitate new approaches to the application of HSV-1 as an oncolytic virus.Keywords
This publication has 56 references indexed in Scilit:
- Structure and Functional Evaluation of Tendon–Skeletal Muscle Constructs Engineeredin VitroTissue Engineering, 2006
- Employment of liver tissue slice analysis to assay hepatotoxicity linked to replicative and nonreplicative adenoviral agentsCancer Gene Therapy, 2006
- An Update on the Surgical Management of Rectal CancerCurrent Surgery, 2005
- Ex vivo transduction of human dermal tissue structures for autologous implantation production and delivery of therapeutic proteinsMolecular Therapy, 2005
- War and peace at mucosal surfacesNature Reviews Immunology, 2004
- Carcinoembryonic antigen directed herpes viral oncolysis improves selectivity and activity in colorectal cancerSurgery, 2004
- Antibody-targeted cell fusionNature Biotechnology, 2004
- Oncolytic herpes simplex virus vectors for cancer virotherapyCancer Gene Therapy, 2002
- Regulation of Herpes Simplex Virus 1 Replication Using Tumor-Associated PromotersAnnals of Surgery, 2002
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976